The ADDA offers pilot funding opportunities in collaboration with the UAB Center for Emerging Drug Discovery, the UAB Center for Clinical and Translational Science and with the UAB Comprehensive Cancer Center. Grants are for $50,000 per year for 2 years, with the second year of funding dependent on progress made in the first year. Funds can be utilized for any aspect of drug discovery and development, including - but not limited to - target validation, assay development for high-throughput screening, molecular modeling and medicinal chemistry efforts, or proof of concept studies in animals. Upon funding, a multi-disciplinary team will be assembled, consisting of members with relevant expertise, including cell biology, pharmacology, medicinal chemistry, HTS assay development as well as clinical knowledge. This team, which will meet quarterly, will help create a compound progression pathway and guide the project through the drug discovery and development pipeline. In addition to scientific merit, applications will be evaluated for intellectual property and commercialization aspects, in collaboration with the UAB Research Foundation and Southern Research Institute.